Dashboard PDUFA PDUFA History Dilution Watch Downside Radar Missed Milestones Earnings Big Movers Blog

🎤 Upcoming Biotech Conferences

Loading conferences...
Free to browse, no account needed Follow the companies behind these drugs with free AI briefings, catalyst countdowns and dilution alerts.

KRRO-121

Other · developed by Korro Bio

Phase 1/2 Most advanced trial
KRRO Developer
1 Registered trials

What is KRRO-121?

KRRO-121 is a subcutaneously injected agent studied in urea cycle disorders, including ornithine transcarbamylase deficiency, arginase 1 deficiency, and argininosuccinate lyase deficiency.

Summary written with AI from the sources listed at the end of this page.

At a glance

Drug type
Other
Therapy area
Neurology
Developer
Korro Bio, Inc. (KRRO)
FDA status
Investigational, not approved in the US. Most advanced trial: Phase 1/2

🧪 Clinical trials

TrialPhaseConditionStatusSponsor
NCT07773246 Phase 1/2 Urea Cycle Disorders, Inborn Recruiting KRRO

Trials of the companies BioRadar tracks, from ClinicalTrials.gov, most advanced phase first.

Conditions studied

Arginase 1 DeficiencyArgininosuccinate Lyase DeficiencyArgininosuccinate SynthaseCarbamylphosphate Synthetase ICitrin DeficiencyN-acetyl Glutamate - SynthetaseNAGS DeficiencyOrnithine Transcarbamylase (OTC) DeficiencyOrnithine Transporter Mitochondrial 1Urea Cycle DisordersUrea Cycle Disorders, Inborn

More from Korro Bio

Sources

Updated Oct 25, 2026. Something wrong or missing? Report it on the KRRO page.

Follow KRRO, the company behind KRRO-121

See KRRO's upcoming FDA decisions, trial readouts, cash runway and dilution risk, updated every day from SEC, FDA and ClinicalTrials.gov filings.

KRRO catalysts and pipeline →
Data: FDA (Drugs@FDA, Purple Book, DailyMed), NIH (NCI Thesaurus, GSRS, RxNorm), ClinicalTrials.gov • Informational purposes only, not medical or investment advice. • All drugs A–Z

This data is for informational purposes only, not investment advice. BioRadar does not provide buy/sell recommendations. Past performance does not guarantee future results. Always do your own due diligence.